What happened
WHO and partners launched a 2026–2035 roadmap for hypertensive disorders of pregnancy, including pre-eclampsia. It organizes action across five areas: research and innovation, norms and standards, access to products, implementation, and advocacy and accountability.
Why it matters
Hypertensive disorders complicate an estimated 10–15% of pregnancies and remain a major cause of maternal and newborn harm. A shared roadmap can align research, procurement and care delivery, but publication alone does not fund or implement those changes.
What to watch
Country adoption, investment in diagnostics and medicines, implementation in lower-resource settings, and public reporting against the roadmap’s 2035 targets.
